In summary, the decrease in blood glucose level mediated by FMC was associated with a significant reduction in insulin resistance, as revealed by the plasma insulin content and blood glucose levels in vivo in a KK-Ay mouse model of T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.